These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 12526160)

  • 21. PEGylated adenovirus for targeted gene therapy.
    O'Riordan CR; Song A
    Methods Mol Biol; 2008; 434():133-60. PubMed ID: 18470643
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting adenoviral vectors by using the extracellular domain of the coxsackie-adenovirus receptor: improved potency via trimerization.
    Kim J; Smith T; Idamakanti N; Mulgrew K; Kaloss M; Kylefjord H; Ryan PC; Kaleko M; Stevenson SC
    J Virol; 2002 Feb; 76(4):1892-903. PubMed ID: 11799184
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue-targeted in vivo gene transfer coupled with histone deacetylase inhibitor depsipeptide (FK228) enhances adenoviral infection in rat renal cancer allograft model systems.
    Kobayashi M; Okada T; Murakami T; Ozawa K; Kobayashi E; Morita T
    Urology; 2007 Dec; 70(6):1230-6. PubMed ID: 18158067
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene delivery into primary T cells: overview and characterization of a transgenic model for efficient adenoviral transduction.
    Hurez V; Hautton RD; Oliver J; Matthews RJ; Weaver CK
    Immunol Res; 2002; 26(1-3):131-41. PubMed ID: 12403352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta3 subunit expression and increased by reconstitution of integrin alphavbeta3.
    Brüning A; Köhler T; Quist S; Wang-Gohrke S; Moebus VJ; Kreienberg R; Runnebaum IB
    Hum Gene Ther; 2001 Mar; 12(4):391-9. PubMed ID: 11242531
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An adenovirus with enhanced infectivity mediates molecular chemotherapy of ovarian cancer cells and allows imaging of gene expression.
    Hemminki A; Belousova N; Zinn KR; Liu B; Wang M; Chaudhuri TR; Rogers BE; Buchsbaum DJ; Siegal GP; Barnes MN; Gomez-Navarro J; Curiel DT; Alvarez RD
    Mol Ther; 2001 Sep; 4(3):223-31. PubMed ID: 11545613
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CAR- or alphav integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice.
    Mizuguchi H; Koizumi N; Hosono T; Ishii-Watabe A; Uchida E; Utoguchi N; Watanabe Y; Hayakawa T
    Gene Ther; 2002 Jun; 9(12):769-76. PubMed ID: 12040458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adenovirus serotype 5 fiber shaft influences in vivo gene transfer in mice.
    Smith TA; Idamakanti N; Rollence ML; Marshall-Neff J; Kim J; Mulgrew K; Nemerow GR; Kaleko M; Stevenson SC
    Hum Gene Ther; 2003 May; 14(8):777-87. PubMed ID: 12804140
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategies for muscle-specific targeting of adenoviral gene transfer vectors.
    Thirion C; Larochelle N; Volpers C; Dunant P; Stucka R; Holland P; Nalbantoglu J; Kochanek S; Lochmüller H
    Neuromuscul Disord; 2002 Oct; 12 Suppl 1():S30-9. PubMed ID: 12206792
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the primary coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells.
    Nalbantoglu J; Pari G; Karpati G; Holland PC
    Hum Gene Ther; 1999 Apr; 10(6):1009-19. PubMed ID: 10223734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting of high-capacity adenoviral vectors.
    Biermann V; Volpers C; Hussmann S; Stock A; Kewes H; Schiedner G; Herrmann A; Kochanek S
    Hum Gene Ther; 2001 Sep; 12(14):1757-69. PubMed ID: 11560769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New generation adenoviral vectors improve gene transfer by coxsackie and adenoviral receptor-independent cell entry.
    Reynolds PN; Curiel DT
    Kidney Int; 2002 Jan; 61(1 Suppl):S24-31. PubMed ID: 11841608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effective high-capacity gutless adenoviral vectors mediate transgene expression in human glioma cells.
    Candolfi M; Curtin JF; Xiong WD; Kroeger KM; Liu C; Rentsendorj A; Agadjanian H; Medina-Kauwe L; Palmer D; Ng P; Lowenstein PR; Castro MG
    Mol Ther; 2006 Sep; 14(3):371-81. PubMed ID: 16798098
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gene transfer mediated by native versus fibroblast growth factor-retargeted adenoviral vectors into lung cancer cells.
    Qin M; Escuadro B; Sharma S; Batra RK
    Am J Respir Cell Mol Biol; 2005 Mar; 32(3):211-7. PubMed ID: 15626775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preclinical evaluation of a class of infectivity-enhanced adenoviral vectors in ovarian cancer gene therapy.
    Wu H; Han T; Lam JT; Leath CA; Dmitriev I; Kashentseva E; Barnes MN; Alvarez RD; Curiel DT
    Gene Ther; 2004 May; 11(10):874-8. PubMed ID: 14999229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding of adenoviral fiber knob to the coxsackievirus-adenovirus receptor is crucial for transduction of fetal muscle.
    Bilbao R; Srinivasan S; Reay D; Goldberg L; Hughes T; Roelvink PW; Einfeld DA; Wickham TJ; Clemens PR
    Hum Gene Ther; 2003 May; 14(7):645-9. PubMed ID: 12804146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of synthetic cell-penetrating peptides, Pro-rich peptide and octaargine derivatives, as adenovirus vector carrier.
    Kida S; Eto Y; Yoshioka Y; Nakagawa S; Kawasaki K; Maeda M
    Protein Pept Lett; 2010 Feb; 17(2):164-7. PubMed ID: 20214640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A capsid-modified, conditionally replicating oncolytic adenovirus vector expressing TRAIL Leads to enhanced cancer cell killing in human glioblastoma models.
    Wohlfahrt ME; Beard BC; Lieber A; Kiem HP
    Cancer Res; 2007 Sep; 67(18):8783-90. PubMed ID: 17875719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retargeting of adenoviral vector using basic fibroblast growth factor ligand for malignant glioma gene therapy.
    Wang W; Zhu NL; Chua J; Swenson S; Costa FK; Schmitmeier S; Sosnowski BA; Shichinohe T; Kasahara N; Chen TC
    J Neurosurg; 2005 Dec; 103(6):1058-66. PubMed ID: 16381193
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Suppression of ovarian cancer growth via systemic administration with liposome-encapsulated adenovirus-encoding endostatin.
    Yang L; Wang L; Su XQ; Wang L; Chen XC; Li D; Luo ST; Shi HS; Chen LJ; Wang YS
    Cancer Gene Ther; 2010 Jan; 17(1):49-57. PubMed ID: 19609295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.